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Immune system dysregulation occurs during spaceflight and consists of altered peripheral 
leukocyte distribution, reductions in immunocyte function and altered cytokine production 
profiles.   Causes may include stress, confinement, isolation, and disrupted circadian rhythms.   
All of these factors may be replicated to some degree in terrestrial environments.  NASA is 
currently evaluating the potential for a ground-based analog for immune dysregulation, which 
would have utility for mechanistic investigations and countermeasures evaluation.   
 
For ground-based space physiology research, the choice of terrestrial analog must carefully 
match the system of interest.  Antarctica winter-over, consisting of prolonged durations in an 
extreme/dangerous environment, station-based habitation, isolation and disrupted circadian 
rhythms, is potentially a good ground-analog for spaceflight-associated immune dysregulation. 
Of all Antarctica bases, the French-Italian Concordia Station, may be the most appropriate to 
replicate spaceflight/exploration conditions.  Concordia is an interior base located in harsh 
environmental conditions, and has been constructed to house small, international crews in a 
station-environment similar to what should be experienced by deep space astronauts. 
 
The ESA-NASA CHOICE study assessed innate and adaptive immunity, viral reactivation and 
stress factors during Concordia winterover deployment. The study was conducted over two 
winterover missions in 2009 and 2010.  Final study data from NASA participation in these 
missions will be presented. 
 
Acknowledgement: This investigation has been supported by the ESA, NASA, the German National Space Program 
(DLR, 50WB0719/WB0919), the French (IPEV) and Italian (PNRA) polar institutes by BELPSO/PRODEX/ESA 
contracts (C90-380 and C90-391) and by the Concordia crews who has participated with high professionalism and 
great enthusiasm. 
 
  
 
https://ntrs.nasa.gov/search.jsp?R=20110023290 2019-08-30T18:13:09+00:00Z
